Pfizer increases spring vaccination schedule, adding 5 million doses to June shipments

Ottawa — Canada’s promised spring supply of COVID-19 vaccine will increase on Tuesday, with millions of additional doses expected from three different suppliers by Canada Day.

However, the news has shown in many countries that the pandemic still has more misery unleashed, alleviated by continued concerns about the Oxford-AstraZeneca vaccine.

“We are in the final stages of this crisis,” Justin Trudeau said at a press conference in Ottawa. “We need to stay a little longer and stronger. We are getting more and more vaccines every week, so there is reason to hope.”

According to Trudeau, Pfizer and BioNTech will send another 5 million RNA vaccines to Canada in June, bringing total spring shipments to 17.8 million. The company is expected to ship more than 1 million times a week in April and May and more than 2 million times a week in June.

Procurement Minister Anita Anand added that Canada currently expects 4.4 million doses of AstraZeneca vaccine by June 30, with the first shipment of Johnson & Johnson’s single-dose vaccine at the end of April. He said he was arriving at. She still does not know how many doses will be given on that first shipment.

Even without J & J, Canada will receive more than 44 million doses before Canada Day, unless vaccine production and exports are unexpectedly interrupted.

This means that all adults over the age of 18 will be vaccinated sooner, and waiting for a second vaccination may not be as long as the current four months.

In Canada, about 31 million doses are required to provide at least one shot to all adults.

Healthcare professionals across Canada stepped up their efforts to combat vaccine hesitation on Tuesday, following the latest news that all states and territories will stop using the AstraZeneca vaccine for people under the age of 55. We are waiting for further analysis of the risks it may pose.

Health Canada requested the company on Monday for further analysis as reports from Europe increased that a small number of patients developed blood clots after vaccination with AstraZeneca. Most of those patients were women under the age of 55.

Dr. Teresa Tam, Chief Public Health Officer across the country, said he knew this was another difficult development in the endless twists and turns of the pandemic.

But she said the system was working as intended and people could be confident in the Canadian-approved vaccine.

No vaccine-related blood clots have been found in Canada. In Canada, approximately 309,000 doses have been administered from the first shipment two weeks ago to the present. Many states initially booked these doses for people in their 50s and early 60s.

Dr. Dina Hinsho, a health care officer in Alberta, said on Monday that Alberta received 58.500 doses of AstraZeneca and only 900 doses to people under the age of 55.

Others, such as Prince Edward Island, who used AstraZeneca for completely young adults, have so far stopped using it altogether.

Tam warned that despite increased vaccination, Canadians need to be aware that COVID-19 is spreading faster in many parts of the country. It is caused by a variant of the virus that is not only highly contagious, but also makes people sick.

She said hospitalizations increased by 6% last week and the number of patients in need of critical care increased by 14%. Canada now has an average of 4,600 new COVID-19 cases per day, compared to 3,600 cases a week ago.

Mia Loveson

Posted on